The regulatory architecture of the primed pluripotent cell state
Despite extensive research, the gene regulatory architecture governing mammalian cell states remains poorly understood. Here we present an integrative systems biology approach to elucidate the network architecture of primed state pluripotency. Using an unbiased methodology, we identified and experimentally confirmed 132 transcription factors as master regulators (MRs) of mouse epiblast stem cell (EpiSC) pluripotency, many of which were further validated by CRISPR-mediated functional assays. To assemble a comprehensive regulatory network, we silenced each of the 132 MRs to assess their effects on the other MRs and their transcriptional targets, yielding a network of 1273 MR → MR interactions. Network architecture analyses revealed four functionally distinct MR modules (communities), and identified key Speaker and Mediator MRs based on their hierarchical rank and centrality. Our findings elucidate the de-centralized logic of a "communal interaction" model in which the balanced activities of four MR communities maintain primed state pluripotency.
Authors
- Napon Chirathivat (ORCID: https://orcid.org/0000-0003-0296-6100)
- Mariano J. Alvarez (ORCID: https://orcid.org/0000-0002-7503-2491)
- Michael M. Shen (ORCID: https://orcid.org/0000-0002-4042-1657)
- Bo I. Li
- Andrea Califano (ORCID: https://orcid.org/0000-0003-4742-3679)
- Hui Zhao (ORCID: https://orcid.org/0000-0001-8160-6415)
Institutions
- Columbia University Irving Medical Center (US)
- New York Proton Center (US)
- Institut thématique Génétique, génomique et bioinformatique (FR)
- Chan Zuckerberg Initiative (United States) (US)
- Cancer Genetics (United States) (US)
- DarwinHealth (United States) (US)
- Pediatrics and Genetics (US)
- Center for Systems Biology (US)
- Columbia University (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1038/s41467-025-57894-4
- Citations
- 1
- Primary Topic
- Pluripotent Stem Cells Research
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- National Institutes of Health
- Irving Medical Center, Columbia University
- National Cancer Institute